Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan

Ulan Kozhamkulov, Ainur Akhmetova, Saule Rakhimova, Elena Belova, Arike Alenova, Venera Bismilda, Lyailya Chingissova, Shahimurat Ismailov, Erlan Ramanculov, Kuvat Momynaliev

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Kazakhstan is one of the 14 countries with a high rate of morbidity due to multidrugresistant tuberculosis (MDR TB) in WHO European region. The aim of our study was to characterize mutations associated with drug resistance to rifampicin and isoniazid in Mycobacterium tuberculosis isolates from Kazakhstan. M. tuberculosis strains were isolated from TB patients in different regions of Kazakhstan. A drug susceptibility test was performed on Lowenstein-Jensen medium using the absolute concentration method. Sequencing analysis was performed of the rpoB rifampicin resistance-determining region and the katG gene, the oxyR-ahpC intergenic region, and the inhA promoter region in 259 MDR M. tuberculosis isolates, in 51 isoniazid-resistant isolates, and in 13 rifampicin-resistant isolates. The mutational analysis revealed that the most frequent mutations associated with rifampicin and isoniazid resistance in M. tuberculosis are the substitutions at codons 531 (82.7%) and 315 (98.4%) in the rpoB and kat G genes, espectively. In addition, we have found mutations with lower frequency at codons 526 (8.4%), 533 (1.5%), and 516 (1.1%) in the rpoB gene. In 6.2% of the isolates, no mutations were found in the rpoB gene. The findings of this study provide useful data for a better understanding of the mutation spectrum of isoniazid and rifampicin resistance among strains isolated from patients in Kazakhstan. Our results are also useful for the development of diagnostic tests of MDR M. tuberculosis.

Original languageEnglish
Pages (from-to)253-255
Number of pages3
JournalJapanese Journal of Infectious Diseases
Volume64
Issue number3
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Kazakhstan
Isoniazid
Rifampin
Mycobacterium tuberculosis
Mutation
Multidrug-Resistant Tuberculosis
Mycobacterium
Codon
Genes
Intergenic DNA
Routine Diagnostic Tests
Drug Resistance
Genetic Promoter Regions
Tuberculosis
Morbidity
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan. / Kozhamkulov, Ulan; Akhmetova, Ainur; Rakhimova, Saule; Belova, Elena; Alenova, Arike; Bismilda, Venera; Chingissova, Lyailya; Ismailov, Shahimurat; Ramanculov, Erlan; Momynaliev, Kuvat.

In: Japanese Journal of Infectious Diseases, Vol. 64, No. 3, 2011, p. 253-255.

Research output: Contribution to journalArticle

Kozhamkulov, Ulan ; Akhmetova, Ainur ; Rakhimova, Saule ; Belova, Elena ; Alenova, Arike ; Bismilda, Venera ; Chingissova, Lyailya ; Ismailov, Shahimurat ; Ramanculov, Erlan ; Momynaliev, Kuvat. / Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan. In: Japanese Journal of Infectious Diseases. 2011 ; Vol. 64, No. 3. pp. 253-255.
@article{21a3fa4e552045d0b1761ef2726fed77,
title = "Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan",
abstract = "Kazakhstan is one of the 14 countries with a high rate of morbidity due to multidrugresistant tuberculosis (MDR TB) in WHO European region. The aim of our study was to characterize mutations associated with drug resistance to rifampicin and isoniazid in Mycobacterium tuberculosis isolates from Kazakhstan. M. tuberculosis strains were isolated from TB patients in different regions of Kazakhstan. A drug susceptibility test was performed on Lowenstein-Jensen medium using the absolute concentration method. Sequencing analysis was performed of the rpoB rifampicin resistance-determining region and the katG gene, the oxyR-ahpC intergenic region, and the inhA promoter region in 259 MDR M. tuberculosis isolates, in 51 isoniazid-resistant isolates, and in 13 rifampicin-resistant isolates. The mutational analysis revealed that the most frequent mutations associated with rifampicin and isoniazid resistance in M. tuberculosis are the substitutions at codons 531 (82.7{\%}) and 315 (98.4{\%}) in the rpoB and kat G genes, espectively. In addition, we have found mutations with lower frequency at codons 526 (8.4{\%}), 533 (1.5{\%}), and 516 (1.1{\%}) in the rpoB gene. In 6.2{\%} of the isolates, no mutations were found in the rpoB gene. The findings of this study provide useful data for a better understanding of the mutation spectrum of isoniazid and rifampicin resistance among strains isolated from patients in Kazakhstan. Our results are also useful for the development of diagnostic tests of MDR M. tuberculosis.",
author = "Ulan Kozhamkulov and Ainur Akhmetova and Saule Rakhimova and Elena Belova and Arike Alenova and Venera Bismilda and Lyailya Chingissova and Shahimurat Ismailov and Erlan Ramanculov and Kuvat Momynaliev",
year = "2011",
language = "English",
volume = "64",
pages = "253--255",
journal = "Japanese Journal of Infectious Diseases",
issn = "1344-6304",
publisher = "National Institute of Health",
number = "3",

}

TY - JOUR

T1 - Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan

AU - Kozhamkulov, Ulan

AU - Akhmetova, Ainur

AU - Rakhimova, Saule

AU - Belova, Elena

AU - Alenova, Arike

AU - Bismilda, Venera

AU - Chingissova, Lyailya

AU - Ismailov, Shahimurat

AU - Ramanculov, Erlan

AU - Momynaliev, Kuvat

PY - 2011

Y1 - 2011

N2 - Kazakhstan is one of the 14 countries with a high rate of morbidity due to multidrugresistant tuberculosis (MDR TB) in WHO European region. The aim of our study was to characterize mutations associated with drug resistance to rifampicin and isoniazid in Mycobacterium tuberculosis isolates from Kazakhstan. M. tuberculosis strains were isolated from TB patients in different regions of Kazakhstan. A drug susceptibility test was performed on Lowenstein-Jensen medium using the absolute concentration method. Sequencing analysis was performed of the rpoB rifampicin resistance-determining region and the katG gene, the oxyR-ahpC intergenic region, and the inhA promoter region in 259 MDR M. tuberculosis isolates, in 51 isoniazid-resistant isolates, and in 13 rifampicin-resistant isolates. The mutational analysis revealed that the most frequent mutations associated with rifampicin and isoniazid resistance in M. tuberculosis are the substitutions at codons 531 (82.7%) and 315 (98.4%) in the rpoB and kat G genes, espectively. In addition, we have found mutations with lower frequency at codons 526 (8.4%), 533 (1.5%), and 516 (1.1%) in the rpoB gene. In 6.2% of the isolates, no mutations were found in the rpoB gene. The findings of this study provide useful data for a better understanding of the mutation spectrum of isoniazid and rifampicin resistance among strains isolated from patients in Kazakhstan. Our results are also useful for the development of diagnostic tests of MDR M. tuberculosis.

AB - Kazakhstan is one of the 14 countries with a high rate of morbidity due to multidrugresistant tuberculosis (MDR TB) in WHO European region. The aim of our study was to characterize mutations associated with drug resistance to rifampicin and isoniazid in Mycobacterium tuberculosis isolates from Kazakhstan. M. tuberculosis strains were isolated from TB patients in different regions of Kazakhstan. A drug susceptibility test was performed on Lowenstein-Jensen medium using the absolute concentration method. Sequencing analysis was performed of the rpoB rifampicin resistance-determining region and the katG gene, the oxyR-ahpC intergenic region, and the inhA promoter region in 259 MDR M. tuberculosis isolates, in 51 isoniazid-resistant isolates, and in 13 rifampicin-resistant isolates. The mutational analysis revealed that the most frequent mutations associated with rifampicin and isoniazid resistance in M. tuberculosis are the substitutions at codons 531 (82.7%) and 315 (98.4%) in the rpoB and kat G genes, espectively. In addition, we have found mutations with lower frequency at codons 526 (8.4%), 533 (1.5%), and 516 (1.1%) in the rpoB gene. In 6.2% of the isolates, no mutations were found in the rpoB gene. The findings of this study provide useful data for a better understanding of the mutation spectrum of isoniazid and rifampicin resistance among strains isolated from patients in Kazakhstan. Our results are also useful for the development of diagnostic tests of MDR M. tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=79958031478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958031478&partnerID=8YFLogxK

M3 - Article

VL - 64

SP - 253

EP - 255

JO - Japanese Journal of Infectious Diseases

JF - Japanese Journal of Infectious Diseases

SN - 1344-6304

IS - 3

ER -